Paul Kim Biography and Net Worth

CFO of Fulgent Genetics

Paul Kim is the CFO at Fulgent Genetics, a role he has held since 2016. Fulgent is a leader in next generation sequencing, dedicated to creating affordable and flexible genetic testing.

Prior to joining Fulgent, Kim was the CFO for Cogent Systems, a manufacturer of automated fingerprint identification and facial recognition systems. The company was acquired by 3M in 2010. Cogent’s founder, Ming Hsieh, went on to found Fulgent in 2011, where Kim would later join him after a brief period of retirement.

Before his tenures at Cogent and Fulgent, Kim served in executive finance positions for a variety of companies, including JNI Corporation, a storage area network technology company, Datafusion, a software development company, and Interlink Computer Sciences, an enterprise software company. He also worked as an audit manager at Coopers and Lybrand L.L.P.

Kim earned his bachelor’s degree in economics at the University of California, Berkeley, and he is a certified public accountant.

What is Paul Kim's net worth?: The estimated net worth of Paul Kim is at least $5.88 million as of March 5th, 2025. Mr. Kim owns 348,282 shares of Fulgent Genetics stock worth more than $5,879,000 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Kim may own. Additionally, Mr. Kim receives an annual salary of $879,610.00 as CFO at Fulgent Genetics. Learn More about Paul Kim's net worth.
How old is Paul Kim?: Mr. Kim is currently 57 years old. There are 3 older executives and no younger executives at Fulgent Genetics. The oldest executive at Fulgent Genetics is Mr. Ming Hsieh, Chairman & CEO, who is 68 years old. Learn More on Paul Kim's age.
What is Paul Kim's salary?: As the CFO of Fulgent Genetics, Inc., Mr. Kim earns $879,610.00 per year. The highest earning executive at Fulgent Genetics is Mr. Ming Hsieh, Chairman & CEO, who commands a salary of $2,310,000.00 per year. Learn More on Paul Kim's salary.
How do I contact Paul Kim?: The corporate mailing address for Mr. Kim and other Fulgent Genetics executives is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Fulgent Genetics can also be reached via phone at (626) 350-0537 and via email at nborsje@blueshirtgroup.com. Learn More on Paul Kim's contact information.
Has Paul Kim been buying or selling shares of Fulgent Genetics?: Within the last three months, Paul Kim has bought $1,596,000.00 in shares of Fulgent Genetics stock. Most recently, on Wednesday, March 5th, Paul Kim bought 100,000 shares of Fulgent Genetics stock. The stock was acquired at an average cost of $15.96 per share, with a total value of $1,596,000.00. Following the completion of the transaction, the chief financial officer now directly owns 348,282 shares of the company's stock, valued at $5,558,580.72. Learn More on Paul Kim's trading history.
Who are Fulgent Genetics' active insiders?: Fulgent Genetics' insider roster includes John Bolger (Director), Hanlin Gao (Insider), Ming Hsieh (Chairman & CEO ), Paul Kim (CFO), and Jian Xie (COO). Learn More on Fulgent Genetics' active insiders.
Are insiders buying or selling shares of Fulgent Genetics?: During the last twelve months, Fulgent Genetics insiders bought shares 1 times. They purchased a total of 100,000 shares worth more than $1,596,000.00. During the last twelve months, insiders at the sold shares 7 times. They sold a total of 7,737 shares worth more than $161,038.30. The most recent insider tranaction occured on March, 5th when CFO Paul Kim bought 100,000 shares worth more than $1,596,000.00. Insiders at Fulgent Genetics own 31.8% of the company. Learn More about insider trades at Fulgent Genetics.
Information on this page was last updated on 3/5/2025.

Paul Kim Insider Trading History at Fulgent Genetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Buy	100,000	$15.96	$1,596,000.00	348,282
8/27/2024	Sell	733	$22.83	$16,734.39	211,155
12/4/2023	Sell	1,437	$27.57	$39,618.09	200,460
11/16/2023	Sell	1,307	$27.25	$35,615.75	201,897
8/28/2023	Sell	10,299	$33.62	$346,252.38	215,553
8/17/2023	Sell	1,798	$33.88	$60,916.24	225,852
6/2/2023	Sell	1,403	$40.30	$56,540.90	228,890
9/6/2022	Sell	662	$41.39	$27,400.18	149,507
6/2/2022	Sell	415	$55.10	$22,866.50	153,162
5/16/2022	Sell	1,191	$53.38	$63,575.58	153,577
3/3/2022	Sell	454	$56.31	$25,564.74
12/2/2021	Sell	620	$83.16	$51,559.20
11/18/2021	Sell	500	$97.46	$48,730.00
11/16/2021	Sell	1,669	$95.50	$159,389.50
9/2/2021	Sell	607	$94.29	$57,234.03	135,176
8/16/2021	Sell	1,682	$95.12	$159,991.84
6/4/2021	Sell	789	$74.26	$58,591.14	142,977
6/2/2021	Sell	461	$71.34	$32,887.74	142,977
5/25/2021	Sell	10,358	$72.94	$755,512.52	161,438
5/18/2021	Sell	1,155	$70.71	$81,670.05	171,796
12/9/2020	Sell	10,662	$51.60	$550,159.20	191,521
12/2/2020	Sell	29,949	$46.58	$1,395,024.42	231,502
11/16/2020	Sell	100,000	$46.17	$4,617,000.00	235,899
9/2/2020	Sell	425	$28.32	$12,036.00	335,899
8/19/2020	Sell	136,643	$42.12	$5,755,403.16	471,109
8/17/2020	Sell	111,236	$41.65	$4,632,979.40	471,109
8/11/2020	Sell	1,396	$42.06	$58,715.76	472,417
6/2/2020	Sell	425	$18.06	$7,675.50	433,813
5/12/2020	Sell	1,421	$16.31	$23,176.51	434,238
8/12/2019	Sell	12,389	$11.50	$142,473.50	412,250
5/13/2019	Sell	1,404	$5.50	$7,722.00
3/5/2019	Sell	1,165	$4.67	$5,440.55	400,015
11/13/2018	Sell	1,446	$3.50	$5,061.00
8/13/2018	Sell	1,405	$4.50	$6,322.50	382,626
5/14/2018	Sell	1,370	$3.72	$5,096.40	384,031
3/8/2018	Sell	1,628	$3.76	$6,121.28	385,401
11/13/2017	Sell	1,573	$3.22	$5,065.06
8/11/2017	Sell	6,134	$5.71	$35,025.14	388,602

See Full Table

Paul Kim Buying and Selling Activity at Fulgent Genetics

Fulgent Genetics Company Overview

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Today's Range

Now: $16.88

$16.51

$16.94

50 Day Range

MA: $16.81

$15.28

$18.59

2 Week Range

Now: $16.88

$14.57

$25.11

Volume

143,248 shs

Average Volume

242,024 shs

Market Capitalization

$521.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Paul Kim Biography and Net Worth

What is Paul Kim's net worth?

How old is Paul Kim?

What is Paul Kim's salary?

How do I contact Paul Kim?

Has Paul Kim been buying or selling shares of Fulgent Genetics?

Who are Fulgent Genetics' active insiders?

Are insiders buying or selling shares of Fulgent Genetics?